European Patent Office has granted Persica’s first patent
London, UK, 03 February 2022 – Persica is delighted to announce that the European Patent Office has granted Persica’s first patent “Antibiotic Formulations for Lower Back Pain – EP3541442” which provides a foundation for our intellectual property.
Persica’s novel antibiotic formulation for intradiscal administration of antibiotic to treat patients with Chronic Lower Back Pain, PP353, is in international Phase 1b clinical trials.
Comments are closed.